PTPI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Petros Pharmaceuticals Inc (PTPI).


$3.94M Market Cap.

As of 04/01/2025 5:00 PM ET (MRY) • Disclaimer

PTPI Market Cap. (MRY)


PTPI Shares Outstanding (MRY)


PTPI Assets (MRY)


Total Assets

$10.64M

Total Liabilities

$18.10M

Total Investments

$0

PTPI Income (MRY)


Revenue

$5.11M

Net Income

-$14.32M

Operating Expense

$21.58M

PTPI Cash Flow (MRY)


CF Operations

-$2.60M

CF Investing

-$24.59K

CF Financing

-$7.00M

PTPI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PTPI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$10,635,310 (-68.53%)

$33,795,795 (4.24%)

$32,421,214 (-51.89%)

$67,390,058 (-3.53%)

Assets Current

$7,294,278 (-64.23%)

$20,390,396 (39.01%)

$14,667,905 (-51.98%)

$30,542,695 (17.90%)

Assets Non-Current

$3,341,032 (-75.08%)

$13,405,399 (-24.49%)

$17,753,309 (-51.82%)

$36,847,363 (-16.16%)

Goodwill & Intangible Assets

$3,204,354 (-64.28%)

$8,971,737 (-26.73%)

$12,244,484 (-51.59%)

$25,293,149 (-21.35%)

Shareholders Equity

-$7,467,578 (-161.86%)

$12,071,041 (-27.73%)

$16,702,467 (-53.01%)

$35,544,964 (103.47%)

Property Plant & Equipment Net

$136,678 (-46.45%)

$255,216 (-35.82%)

$397,649 (705.01%)

$49,397 (-23.12%)

Cash & Equivalents

$3,709,971 (-72.18%)

$13,336,975 (41.49%)

$9,426,264 (-60.47%)

$23,847,572 (39.14%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,999,014 (7.36%)

$2,793,290 (53.89%)

$1,815,113 (249.30%)

$519,649 (-31.67%)

Trade & Non-Trade Receivables

$416,076 (-81.31%)

$2,226,151 (5.49%)

$2,110,246 (-14.06%)

$2,455,386 (-52.35%)

Trade & Non-Trade Payables

$2,328,964 (35.94%)

$1,713,253 (-5.16%)

$1,806,399 (-60.37%)

$4,557,969 (-18.75%)

Accumulated Retained Earnings (Deficit)

-$113,208,371 (-14.48%)

-$98,889,581 (-9.00%)

-$90,726,393 (-28.35%)

-$70,688,820 (-14.56%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$7,248,635 (-9.55%)

$8,013,914 (-15.45%)

$9,477,776 (0%)

$0 (0%)

Debt Current

$7,248,635 (526.75%)

$1,156,550 (6.14%)

$1,089,683 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$6,857,364 (-18.25%)

$8,388,093 (0%)

$0 (0%)

Total Liabilities

$18,102,888 (-15.07%)

$21,315,772 (35.61%)

$15,718,747 (-50.64%)

$31,845,094 (-39.21%)

Liabilities Current

$18,027,665 (67.38%)

$10,770,751 (52.39%)

$7,067,976 (-77.19%)

$30,980,076 (-26.05%)

Liabilities Non-Current

$75,223 (-99.29%)

$10,545,021 (21.90%)

$8,650,771 (900.07%)

$865,018 (-91.75%)

PTPI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$5,112,043 (-12.20%)

$5,822,388 (-2.83%)

$5,992,054 (-23.29%)

$7,811,264 (-18.29%)

Cost of Revenue

$1,212,700 (-25.66%)

$1,631,220 (-28.75%)

$2,289,418 (43.13%)

$1,599,566 (-60.47%)

Selling General & Administrative Expense

$8,749,102 (-5.53%)

$9,261,471 (-24.14%)

$12,209,162 (-21.70%)

$15,593,233 (-0.52%)

Research & Development Expense

$2,615,050 (8.55%)

$2,409,094 (38.43%)

$1,740,280 (-2.70%)

$1,788,491 (289.11%)

Operating Expenses

$21,578,993 (44.31%)

$14,953,532 (-36.69%)

$23,618,385 (-2.64%)

$24,259,714 (6.43%)

Interest Expense

$560,909 (4.62%)

$536,138 (-10.05%)

$596,018 (61.67%)

$368,660 (-87.92%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$14,318,790 (-75.41%)

-$8,163,188 (59.26%)

-$20,037,573 (-122.97%)

-$8,986,676 (56.35%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$14,318,790 (-75.41%)

-$8,163,188 (59.26%)

-$20,037,573 (-122.97%)

-$8,986,676 (56.35%)

Preferred Dividends Income Statement Impact

$12,478,369 (120.81%)

$5,651,211 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$26,797,159 (-93.98%)

-$13,814,399 (31.06%)

-$20,037,573 (-122.97%)

-$8,986,676 (56.35%)

Weighted Average Shares

$8,026,038 (268.84%)

$2,176,017 (5.11%)

$2,070,210 (90.11%)

$1,088,977 (103.90%)

Weighted Average Shares Diluted

$8,026,038 (268.84%)

$2,176,017 (5.11%)

$2,070,210 (90.11%)

$1,088,977 (103.90%)

Earning Before Interest & Taxes (EBIT)

-$13,757,881 (-80.38%)

-$7,627,050 (60.77%)

-$19,441,555 (-125.59%)

-$8,618,016 (54.55%)

Gross Profit

$3,899,343 (-6.96%)

$4,191,168 (13.19%)

$3,702,636 (-40.39%)

$6,211,698 (12.67%)

Operating Income

-$17,679,650 (-64.27%)

-$10,762,364 (45.96%)

-$19,915,749 (-10.35%)

-$18,048,016 (-4.43%)

PTPI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$24,587 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

-$6,999,366 (-160.67%)

$11,537,240 (810.43%)

-$1,623,983 (-108.75%)

$18,569,909 (-38.72%)

Net Cash Flow from Operations

-$2,603,051 (65.87%)

-$7,626,529 (40.41%)

-$12,797,325 (-7.88%)

-$11,862,031 (22.50%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$9,627,004 (-346.17%)

$3,910,711 (127.12%)

-$14,421,308 (-314.99%)

$6,707,878 (-55.26%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$24,587 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$765,279 (47.72%)

-$1,463,862 (9.86%)

-$1,623,983 (77.41%)

-$7,187,529 (-182.29%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$15,000,003 (0%)

$0 (0%)

$25,757,438 (19.41%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$197,215 (-52.73%)

$417,230 (-65.09%)

$1,195,076 (-8.43%)

$1,305,150 (0%)

Depreciation Amortization & Accretion

$2,943,748 (-13.80%)

$3,415,179 (-40.25%)

$5,715,969 (-18.13%)

$6,981,968 (3.39%)

PTPI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

76.30% (5.97%)

72.00% (16.50%)

61.80% (-22.26%)

79.50% (37.78%)

Profit Margin

-524.20% (-120.90%)

-237.30% (29.04%)

-334.40% (-190.78%)

-115.00% (46.59%)

EBITDA Margin

-211.50% (-192.53%)

-72.30% (68.44%)

-229.10% (-996.17%)

-20.90% (83.63%)

Return on Average Equity (ROAE)

-793.70% (-580.70%)

-116.60% (-56.09%)

-74.70% (-95.04%)

-38.30% (76.28%)

Return on Average Assets (ROAA)

-123.50% (-194.75%)

-41.90% (7.51%)

-45.30% (-206.08%)

-14.80% (53.89%)

Return on Sales (ROS)

-269.10% (-105.42%)

-131.00% (59.63%)

-324.50% (-194.20%)

-110.30% (44.41%)

Return on Invested Capital (ROIC)

-417.00% (-512.33%)

-68.10% (46.71%)

-127.80% (-306.46%)

61.90% (-60.62%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.12 (46.85%)

-0.22 (7.88%)

-0.24 (94.03%)

-4.04 (-253.11%)

Price to Sales Ratio (P/S)

0.62 (17.27%)

0.53 (-34.53%)

0.81 (-82.66%)

4.64 (88.85%)

Price to Book Ratio (P/B)

-0.53 (-305.45%)

0.26 (-11.07%)

0.29 (-76.54%)

1.23 (-49.92%)

Debt to Equity Ratio (D/E)

-2.42 (-237.26%)

1.77 (87.67%)

0.94 (5.02%)

0.9 (-70.12%)

Earnings Per Share (EPS)

-3.34 (47.40%)

-6.35 (34.40%)

-9.68 (-17.33%)

-8.25 (78.57%)

Sales Per Share (SPS)

0.64 (-76.20%)

2.68 (-7.53%)

2.89 (-59.65%)

7.17 (-59.93%)

Free Cash Flow Per Share (FCFPS)

-0.33 (90.67%)

-3.5 (43.30%)

-6.18 (43.25%)

-10.89 (62.00%)

Book Value Per Share (BVPS)

-0.93 (-116.77%)

5.55 (-31.25%)

8.07 (-75.28%)

32.64 (-0.21%)

Tangible Assets Book Value Per Share (TABVPS)

0.93 (-91.88%)

11.41 (17.05%)

9.75 (-74.79%)

38.66 (-45.23%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (-200.00%)

1 (0%)

0 (0%)

-4 (-33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.68 (-143.89%)

1.54 (738.17%)

-0.24 (98.95%)

-22.86 (-411.34%)

Asset Turnover

0.24 (34.09%)

0.18 (30.37%)

0.14 (4.65%)

0.13 (-13.42%)

Current Ratio

0.41 (-78.61%)

1.89 (-8.77%)

2.08 (110.45%)

0.99 (59.55%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$2,627,638 (65.55%)

-$7,626,529 (40.41%)

-$12,797,325 (-7.88%)

-$11,862,031 (22.52%)

Enterprise Value (EV)

$7,298,808 (212.66%)

-$6,478,349 (-295.95%)

$3,306,142 (-91.16%)

$37,395,784 (-31.48%)

Earnings Before Tax (EBT)

-$14,318,790 (-75.41%)

-$8,163,188 (59.26%)

-$20,037,573 (-122.97%)

-$8,986,676 (59.18%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$10,814,133 (-156.75%)

-$4,211,871 (69.31%)

-$13,725,586 (-738.95%)

-$1,636,048 (86.60%)

Invested Capital

-$7,058,045 (-180.85%)

$8,730,246 (-33.66%)

$13,160,266 (203.37%)

-$12,730,739 (10.13%)

Working Capital

-$10,733,387 (-211.58%)

$9,619,645 (26.58%)

$7,599,929 (1837.60%)

-$437,381 (97.26%)

Tangible Asset Value

$7,430,956 (-70.07%)

$24,824,058 (23.03%)

$20,176,730 (-52.07%)

$42,096,909 (11.68%)

Market Capitalization

$3,944,858 (27.11%)

$3,103,507 (-35.68%)

$4,824,970 (-88.98%)

$43,790,216 (1.88%)

Average Equity

$3,376,249 (-71.51%)

$11,848,882 (-55.85%)

$26,835,264 (14.43%)

$23,451,457 (84.02%)

Average Assets

$21,702,637 (-34.24%)

$33,001,875 (-25.43%)

$44,257,936 (-26.92%)

$60,562,410 (-5.53%)

Invested Capital Average

$3,299,240 (-70.55%)

$11,202,797 (-26.34%)

$15,207,958 (209.19%)

-$13,928,209 (-15.50%)

Shares

10,014,872 (355.00%)

2,201,069 (6.29%)

2,070,802 (57.47%)

1,315,022 (34.62%)